SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Yue Ling)
 

Sökning: WFRF:(Yue Ling) > (2003-2004) > Enhanced mucosal im...

Enhanced mucosal immunoglobulin A response of intranasal adenoviral vector human immunodeficiency virus vaccine and localization in the central nervous system.

Lemiale, Franck (författare)
Kong, Wing-pui (författare)
Akyürek, Levent, 1966 (författare)
Gothenburg University,Göteborgs universitet,Wallenberglaboratoriet,Wallenberg Laboratory
visa fler...
Ling, Xu (författare)
Huang, Yue (författare)
Chakrabarti, Bimal K (författare)
Eckhaus, Michael (författare)
Nabel, Gary J (författare)
visa färre...
 (creator_code:org_t)
2003
2003
Engelska.
Ingår i: Journal of Virology. - 0022-538X. ; 77:18, s. 10078-87
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Replication-defective adenovirus (ADV) vectors represent a promising potential platform for the development of a vaccine for AIDS. Although this vector is typically administered intramuscularly, it would be desirable to induce mucosal immunity by delivery through alternative routes. In this study, the immune response and biodistribution of ADV vectors delivered by different routes were evaluated. ADV vectors expressing human immunodeficiency virus type 1 (HIV-1) Gag, Pol, and Env were delivered intramuscularly or intranasally into mice. Intranasal immunization induced greater HIV-specific immunoglobulin A (IgA) responses in mucosal secretions and sera than in animals with intramuscular injection, which showed stronger systemic cellular and IgG responses. Administration of the vaccine through an intranasal route failed to overcome prior ADV immunity. Animals exposed to ADV prior to vaccination displayed substantially reduced cellular and humoral immune responses to HIV antigens in both groups, though the reduction was greater in animals immunized intranasally. This inhibition was partially overcome by priming with a DNA expression vector expressing HIV-1 Gag, Pol, and Env before boosting with the viral vector. Biodistribution of recombinant adenovirus (rADV) vectors administered intranasally revealed infection of the central nervous system, specifically in the olfactory bulb, possibly via retrograde transport by olfactory neurons in the nasal epithelium, which may limit the utility of this route of delivery of ADV vector-based vaccines.

Nyckelord

AIDS Vaccines
administration & dosage
immunology
Adenoviridae
genetics
immunology
Administration
Intranasal
Animals
Brain
virology
CD8-Positive T-Lymphocytes
immunology
Female
Genetic Vectors
administration & dosage
immunology
Immunization
Immunoglobulin A
Secretory
biosynthesis
Injections
Intramuscular
Interferon Type II
biosynthesis
Mice
Mice
Inbred BALB C
Vaccines
DNA
immunology

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy